RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+8.07%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$871M
AUM Growth
+$871M
Cap. Flow
+$108M
Cap. Flow %
12.44%
Top 10 Hldgs %
80.56%
Holding
31
New
7
Increased
6
Reduced
3
Closed
9

Top Buys

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$61.2M
2
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
$46.8M
3
RXDX
Ignyta, Inc.
RXDX
$31M
4
RDUS
Radius Health, Inc.
RDUS
$22.5M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$18.7M

Top Sells

1
AVXS
AveXis, Inc. Common Stock
AVXS
$25.9M
2
ZGNX
Zogenix, Inc.
ZGNX
$14.2M
3
LOXO
Loxo Oncology, Inc
LOXO
$12.6M
4
NGNE icon
Neurogene
NGNE
$11.1M
5
ARDX icon
Ardelyx
ARDX
$10.5M

Sector Composition

1 Healthcare 96.54%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ASND icon
1
Ascendis Pharma
ASND
$11.8B
$155M 17.78% 5,580,690 +170,700 +3% +$4.74M
WVE icon
2
Wave Life Sciences
WVE
$1.53B
$132M 15.13% 7,088,651 – –
AVXS
3
DELISTED
AveXis, Inc. Common Stock
AVXS
$108M 12.35% 1,310,046 -315,165 -19% -$25.9M
ACHN
4
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$62.6M 7.18% 13,633,220 – –
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$61.2M 7.02% +2,448,350 New +$61.2M
GTHX
6
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$46.8M 5.37% +2,684,244 New +$46.8M
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
$41.6M 4.77% 4,016,990 +2,991,699 +292% +$31M
ESPR icon
8
Esperion Therapeutics
ESPR
$448M
$33.9M 3.89% 731,531 +26,830 +4% +$1.24M
MYOV
9
DELISTED
Myovant Sciences Ltd.
MYOV
$32.8M 3.77% 2,807,550 +459,128 +20% +$5.37M
BCRX icon
10
BioCryst Pharmaceuticals
BCRX
$1.74B
$28.7M 3.29% 5,162,242 +1,672,447 +48% +$9.3M
RARX
11
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$25.3M 2.91% 1,351,808 – –
RDUS
12
DELISTED
Radius Health, Inc.
RDUS
$22.5M 2.58% +497,157 New +$22.5M
ZGNX
13
DELISTED
Zogenix, Inc.
ZGNX
$21.4M 2.45% 1,474,688 -976,549 -40% -$14.2M
NGNE icon
14
Neurogene
NGNE
$264M
$19.6M 2.25% 1,396,071 -787,976 -36% -$11.1M
AVEO
15
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$18.7M 2.15% +8,435,584 New +$18.7M
ACOR
16
DELISTED
Acorda Therapeutics, Inc.
ACOR
$17.7M 2.04% 900,259 +410,431 +84% +$8.09M
AKBA icon
17
Akebia Therapeutics
AKBA
$833M
$12M 1.38% +836,337 New +$12M
SGMO icon
18
Sangamo Therapeutics
SGMO
$157M
$11M 1.26% +1,250,000 New +$11M
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7.7M 0.88% 2,428,571 – –
TGTX icon
20
TG Therapeutics
TGTX
$4.65B
$7.04M 0.81% 700,000 – –
KALV icon
21
KalVista Pharmaceuticals
KALV
$678M
$4.35M 0.5% 591,070 – –
TARA icon
22
Protara Therapeutics
TARA
$120M
$2.04M 0.23% +1,337,462 New +$2.04M
ARDX icon
23
Ardelyx
ARDX
$1.53B
– – -828,283 Closed -$10.5M
PTGX icon
24
Protagonist Therapeutics
PTGX
$3.67B
– – -636,248 Closed -$8.15M
ONC
25
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
– – -240,000 Closed -$8.79M
1
2